Literature DB >> 25346872

Novel Approaches for Retinal Drug and Gene Delivery.

Stephen J Kim1.   

Abstract

The ARVO 2014 minisymposium on "Novel Approaches for Retinal Drug and Gene Delivery" was held on May 6, 2014 in Orlando, FL. The main intent of the symposium was to review recent advances in retinal drug and gene delivery with specific emphasis on novel approaches that address current limitations and have the potential to translate into clinical practice. The symposium was sponsored by Translational Vision Science and Technology.

Keywords:  intraocular drug delivery; nanotechnology; nonsteroidal anti-inflammatory drugs; retinal gene delivery

Year:  2014        PMID: 25346872      PMCID: PMC4186372          DOI: 10.1167/tvst.3.5.7

Source DB:  PubMed          Journal:  Transl Vis Sci Technol        ISSN: 2164-2591            Impact factor:   3.283


  16 in total

Review 1.  Diabetic retinopathy.

Authors:  David A Antonetti; Ronald Klein; Thomas W Gardner
Journal:  N Engl J Med       Date:  2012-03-29       Impact factor: 91.245

2.  Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines.

Authors:  Scott D Schoenberger; Stephen J Kim; Jinsong Sheng; Kasra A Rezaei; Maziar Lalezary; Edward Cherney
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-27       Impact factor: 4.799

Review 3.  Nonsteroidal anti-inflammatory drugs in ophthalmology.

Authors:  Stephen J Kim; Allan J Flach; Lee M Jampol
Journal:  Surv Ophthalmol       Date:  2010 Mar-Apr       Impact factor: 6.048

4.  The burden of age-related macular degeneration: a value-based medicine analysis.

Authors:  Gary C Brown; Melissa M Brown; Sanjay Sharma; Joshua D Stein; Zachary Roth; Joseph Campanella; George R Beauchamp
Journal:  Trans Am Ophthalmol Soc       Date:  2005

5.  Reduction of interleukin 8 and platelet-derived growth factor levels by topical ketorolac, 0.45%, in patients with diabetic retinopathy.

Authors:  Scott D Schoenberger; Stephen J Kim; Rohan Shah; Jinsong Sheng; Edward Cherney
Journal:  JAMA Ophthalmol       Date:  2014-01       Impact factor: 7.389

6.  Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment.

Authors:  Timothy W Olsen; Xiao Feng; Kathy Wabner; Stanley R Conston; David H Sierra; David V Folden; Morton E Smith; J Douglas Cameron
Journal:  Am J Ophthalmol       Date:  2006-09-20       Impact factor: 5.258

7.  Prevalence of age-related macular degeneration in the United States.

Authors:  David S Friedman; Benita J O'Colmain; Beatriz Muñoz; Sandra C Tomany; Cathy McCarty; Paulus T V M de Jong; Barbara Nemesure; Paul Mitchell; John Kempen
Journal:  Arch Ophthalmol       Date:  2004-04

Review 8.  Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.

Authors:  Uday B Kompella; Aniruddha C Amrite; Rashmi Pacha Ravi; Shelley A Durazo
Journal:  Prog Retin Eye Res       Date:  2013-04-17       Impact factor: 21.198

9.  Safety of intravitreal ketorolac and diclofenac: an electroretinographic and histopathologic study.

Authors:  Stephen J Kim; Neal A Adams; Hassanain S Toma; Marie-Lyne Belair; Jennifer E Thorne; W Richard Green; Douglas A Jabs
Journal:  Retina       Date:  2008-04       Impact factor: 4.256

10.  Nonsteroidal anti-inflammatory drugs for retinal disease.

Authors:  Scott D Schoenberger; Stephen J Kim
Journal:  Int J Inflam       Date:  2013-01-14
View more
  3 in total

Review 1.  Noble Metals and Soft Bio-Inspired Nanoparticles in Retinal Diseases Treatment: A Perspective.

Authors:  Valeria De Matteis; Loris Rizzello
Journal:  Cells       Date:  2020-03-10       Impact factor: 6.600

2.  Design, characterisation and drug release study of polymeric, drug-eluting single layer thin films on the surface of intraocular lenses.

Authors:  Athanasios Karamitsos; Lampros Lamprogiannis; Varvara Karagkiozaki; Argyrios Laskarakis; Lambrini Papadopoulou; Dimitrios Fatouros; Nikolaos Ziakas; Stergios Logothetidis; Ioannis Tsinopoulos
Journal:  IET Nanobiotechnol       Date:  2020-08       Impact factor: 1.847

3.  In Vitro and Ex Vivo Evaluation of Nepafenac-Based Cyclodextrin Microparticles for Treatment of Eye Inflammation.

Authors:  Blanca Lorenzo-Veiga; Patricia Diaz-Rodriguez; Carmen Alvarez-Lorenzo; Thorsteinn Loftsson; Hakon Hrafn Sigurdsson
Journal:  Nanomaterials (Basel)       Date:  2020-04-09       Impact factor: 5.076

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.